Canadian Urological Association (CUA)

Episode NotesPodcast Host Disclosures:Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and VerityDr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).Accreditation:This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits. Obtain Section 3 Credits Here >

Episode NotesPodcast Host Disclosures:Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan, Novartis, Oncohost, Pfizer, Roche, Sanofi/Aventis, Scholar Rock, Surface Oncology, Takeda, Tempest, Up-To-Date, CME events (Peerview, OncLive, MJH, CCO and others), outside the submitted work. Institutional patents filed on molecular alterations and immunotherapy response/toxicity, and ctDNA. Equity: Tempest, Pionyr, Osel, Precede Bio, CureResponse, InnDura. Committees: NCCN, GU Steering Committee, ASCO/ESMO, ACCRU, KidneyCan. Medical writing and editorial assistance support may have been funded by Communications companies in part. No speaker’s bureau. Mentored several non-US citizens on research projects with potential funding (in part) from non-US sources/Foreign Components. The institution (Dana-Farber Cancer Institute) may have received additional independent funding of drug companies or/and royalties potentially involved in research around the subject matter. T. K. Choueiri is supported in part by the Dana-Farber/Harvard Cancer Center Kidney SPORE (2P50CA101942-16) and Program 5P30CA006516-56, the Kohlberg Chair at Harvard Medical School and the Trust Family, Michael Brigham, Pan Mass Challenge, Hinda and Arthur Marcus Fund and Loker Pinard Funds for Kidney Cancer Research at DFCI. Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).Accreditation:This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. After completing the self-assessment questions at the link below, listeners are eligible to claim Section 3 self-assessment credits. Obtain Section 3 Credits Here >

The fourth episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features an introductory discussion on bladder cancer.Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.comReferences from the show:Bladder Cancer CanadaDisclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

The third episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on urinary tract infections in women.Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.comDisclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

The second episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on male voiding disorders and Benign Prostatic Hyperplasia (BPH).Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.comReferences from the show:CUA BPH Guidelines - Google SearchWelcome to Canadian Urological Association | Canadian Urological Association (cua.org) Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Our inaugural 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz! This first podcast in the series focuses on PSA and Prostate Cancer Screening.Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.comReferences from the show:UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis - PMC (nih.gov)UBC & VGH Centre of Excellence | Vancouver Prostate CentreWelcome to Canadian Urological Association | Canadian Urological Association (cua.org) Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Program Chair: Ricardo RendonKidney Cancer Panelists: Melissa Huynh, Lori Wood Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Program Chair: Ricardo RendonKidney Cancer Panelists: Melissa Huynh, Lori Wood Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Program Chair: Ricardo RendonBladder Cancer Panelists: Peter Black, Maria Jiang Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Program Chair: Ricardo RendonBladder Cancer Panelists: Peter Black, Maria Jiang Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Program Chair: Ricardo RendonProstate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Program Chair: Ricardo RendonProstate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACPUniversity of MontrealInstitut de cardiologie de Montreal

Fred Saad, MD, FRCSCHUM, Institut de cancer de Montreal/CRCHUM

Darryl Leong, MDMcMaster University

Fred Saad, MD, FRCSCHUM, Institut de cancer de Montreal/CRCHUM

Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACPUniversity of MontrealInstitut de cardiologie de Montreal

Sponsored by Amgen.Luke LavalleeUrologic Oncologist and Associate ScientistThe Ottawa HospitalOttawa Hospital Research InstituteDisclosures:Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, AstellasGrant/Honorarium: Sanofi

Sponsored by Amgen.Sophie MottardOrthopedic Oncology SurgeonMaisonneuve-Rosemont HospitalCHU Saint-Justine and Santa Cabrini HospitalDisclosures:Payment: Amgen (conference speaker)

Sponsored by Amgen.David KendlerEndocrinologist and Clinical ProfessorUBCDisclosures:Advisory Board: Amgen, Paladin, BiosyntSpeakers Bureau: AmgenPayment: Amgen, Biosynt, Radius Pharma, PaladinGrant/Honorarium: Amgen, Biosynt, Radius Pharma, PaladinClinical Trial: Radius PharmaLeadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)